Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 5201 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Bright Green Corporation

Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Intrommune Therapeutics

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study  

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Psyence Group Inc.

Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference

Read more ››
By: GlobeNewswire - 12 Mar 2024

Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Astrocyte Pharmaceuticals Inc. | Astrocyte Pharmaceuticals Inc.

Ibogaine By David Dardashti Announces New Algorithm to Address PTSD

Read more ››
By: GlobeNewswire - 12 Mar 2024

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Bavarian Nordic A/S

UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obe

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Fractyl Health, Inc.

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  Ceapro Inc.

ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering

Read more ››
By: GlobeNewswire - 12 Mar 2024
Related companies:  ASLAN Pharmaceuticals Ltd.

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024

Foundation for Neglected Disease Research, Bangalore and Blockchain For Impact (BFI) Collaborate to Accelerate Biomedical Innovation

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024
Related companies:  Foundation for Neglected Disease Research

Takeda's 'In Their Shoes' Program Sheds Light on IBD Challenges in South Africa

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024

Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024
Related companies:  Mabwell Biotech Co.,Ltd.

Datasea to Drive Growth in its Acoustic Business via Product Upgrades and U.S. Market Entry

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024

Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024
Related companies:  Endo International plc

NeuroGenesis Reports Positive Results from Phase 2 Extension Study in Progressive Multiple Sclerosis Treated with NG-01 Cell Therapy

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024

Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024
Related companies:  Azenta US, Inc

Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024

Datavant to Provide Patients with Free Digital Access to Their Health Records

Read more ››
By: PR Newswire Association LLC. - 12 Mar 2024
Related companies:  Datavant
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑